Is compounded tirzepatide safe? How it differs from Zepbound

Compounded tirzepatide is not FDA-approved, which means no compounded version has been reviewed by FDA for safety, effectiveness or quality before it is dispensed. Tirzepatide as a molecule has been studied extensively, but those studies were done on the approved products, not on any compounded formulation. Safe use depends on a proper prescription, a licensed pharmacy, a clearly labeled vial and an accurately measured dose. FDA on compounded drugs.

What is compounded tirzepatide?

Tirzepatide acts on two hormone receptors, GIP and GLP-1, which affect appetite, digestion and blood sugar. It is given as an injection under the skin once a week. Tirzepatide injection information.

There are two FDA-approved tirzepatide medicines: Mounjaro, for type 2 diabetes, and Zepbound, for chronic weight management and for moderate to severe obstructive sleep apnea in adults with obesity. Compounded tirzepatide is a separate product prepared by a compounding pharmacy for an individual patient. It is not a generic, and FDA has warned companies not to describe compounded drugs as generic or the same as an approved drug. FDA guidance for telehealth companies.

How is it different from Zepbound and Mounjaro?

	Zepbound and Mounjaro	Compounded tirzepatide
FDA review before sale	Yes: safety, effectiveness and manufacturing quality	No
Clinical trials of the product itself	Yes	No published trials of compounded formulations
Usual form	Pens or vials in set strengths, as described on each product label	Often a multi-dose vial; concentration set by the pharmacy
Ingredients	Approved formula	Set by the pharmacy; may include an added ingredient such as glycine, niacinamide or a vitamin
Who makes it	Manufacturer, under the FDA approval	State-licensed compounding pharmacy or registered outsourcing facility

Concentration is the practical difference to watch. Two compounded vials can hold a different number of milligrams per milliliter, so the volume you draw for the same dose may change when your prescription or pharmacy changes.

Do SURMOUNT results apply to compounded tirzepatide?

No. The SURMOUNT trials that support Zepbound’s approval tested Zepbound at set doses together with diet and exercise. Those results belong to that product. No comparable trials have been published for compounded tirzepatide, so the same results cannot be assumed. Added ingredients such as glycine or niacinamide have not been shown to improve results either. SURMOUNT-1 trial.

What does FDA warn about?

FDA’s page on unapproved GLP-1 drugs, last updated October 1, 2026, lists these concerns: FDA concerns with unapproved GLP-1 drugs.

• Adverse event reports. As of May 31, 2026, FDA had received more than 730 reports of adverse events associated with compounded tirzepatide. A report shows a problem was reported, not that the medicine caused it.
• Dosing errors. Patients and health care professionals have miscalculated doses of compounded GLP-1 drugs, and some patients needed hospital care. Confusion between milligrams, milliliters and syringe “units” is a known cause.
• Doses beyond the approved label. FDA has received reports of higher single doses, more frequent dosing or faster dose increases than the approved labeling describes.
• Fake products. Counterfeit GLP-1 drugs and unlicensed online sellers can supply the wrong ingredient or the wrong amount.
• Opened vials. FDA advises discarding a multi-dose vial within 28 days after first use, even if medicine remains or the label allows longer.

Is compounded tirzepatide still legal?

FDA declared the tirzepatide injection shortage resolved on October 2, 2024, and confirmed that decision on December 19, 2024. The temporary flexibility for compounders ended in March 2025. Compounding is still possible under conditions, but pharmacies generally may not regularly make copies of an approved drug unless a prescriber documents a significant difference for an identified patient. Our guide to GLP-1 compounding rules after the shortages explains what that means. FDA policy update.

Side effects and interactions to know

The most common side effects are nausea, diarrhea, vomiting, constipation, stomach pain and reduced appetite, usually after starting or increasing the dose. Get medical help right away for severe stomach pain that does not go away, signs of an allergic reaction, or a lump or swelling in the neck. Approved tirzepatide products carry a boxed warning about thyroid C-cell tumors, so tell your provider about any personal or family history of medullary thyroid cancer or MEN 2. Tirzepatide side effects.

Tirzepatide slows stomach emptying, which can make birth control pills less effective. The approved labeling recommends switching to a non-oral method or adding a barrier method for 4 weeks after starting treatment and for 4 weeks after each dose increase. Zepbound prescribing information.

What should you confirm before treatment?

1. A licensed provider has reviewed your health history, medicines and goals.
2. The label names a state-licensed pharmacy, and nobody offered the medicine without a prescription.
3. You know the concentration in milligrams per milliliter and what else is in the vial.
4. Your dose is written in milligrams and as the exact amount to draw, and you use the syringes supplied with it.
5. You know the beyond-use date, the storage temperature and how long an opened vial can be used.
6. You know whom to contact about side effects. You can also report them to FDA through MedWatch.

How compounded tirzepatide works at US Quick Health

US Quick Health offers compounded tirzepatide, so this guide is published by a telehealth platform with a commercial interest in arranging access to it. A licensed U.S. provider reviews your online consultation. If treatment is appropriate, the provider chooses the formulation and the dose, and a licensed U.S. compounding pharmacy prepares and ships the medicine with syringes, alcohol swabs and instructions. The consultation is included in the price, and you get a full refund if a prescription is not written. The service is not available in West Virginia, Kansas, New Mexico, Louisiana or Mississippi.

FDA-approved Zepbound and Mounjaro are available through the same consultation. For semaglutide, see is compounded semaglutide safe.